Product Information
LATANOPROST 0.005% EYE DROPS is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.5751 per ML under NDC 59762033302. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 5, 1996. Its Orange Book therapeutic-equivalence code is AT.
Strength
50 ug/mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762033302
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
LATANOPROSTApproval Type
Authorized Generic (NDA)
FDA Application
NDA020597FDA Approved
6/5/1996
TE Code
AT
On Market Since
11/15/2010
Price Statistics
The NADAC for LATANOPROST 0.005% EYE DROPS has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 58.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5751 per ML |
|---|---|
| All-time high | $3.8801 (Feb 12, 2014) |
| All-time low | $1.4484 (Jul 17, 2024) |
| 52-week high | $1.8338 |
| 52-week low | $1.5685 |
| Median price | $1.9930 |
| Average price | $2.1822 |
| Largest weekly change | +22.2% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Latanoprost market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LATANOPROST 0.005% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for LATANOPROST 0.005% EYE DROPS, manufactured by Mylan Pharmaceuticals Inc., is $1.5751 per ML (NDC 59762033302), effective Sep 30, 2026.
How has the price of LATANOPROST 0.005% EYE DROPS changed over time?
Over the history we have for it, the NADAC for LATANOPROST 0.005% EYE DROPS has declined 58.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LATANOPROST 0.005% EYE DROPS?
Since Nov 28, 2013, the NADAC for LATANOPROST 0.005% EYE DROPS has ranged from a low of $1.4484 (Jul 17, 2024) to a high of $3.8801 (Feb 12, 2014), with a median of $1.9930 per ML.
Are there cheaper alternatives to LATANOPROST 0.005% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LATANOPROST 0.005% EYE DROPS, is $1.2377 per ML — about 21% below LATANOPROST 0.005% EYE DROPS.
Who manufactures LATANOPROST 0.005% EYE DROPS?
LATANOPROST 0.005% EYE DROPS (NDC 59762033302) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.